Overview

Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Status:
Unknown status

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the efficacy and safety for treating adult ALL patients with the pediatric protocol.

Phase:

Phase 2

Details

Lead Sponsor:

Japan Adult Leukemia Study Group

Treatments:

6-Mercaptopurine
Asparaginase
Cortisol succinate
Cyclophosphamide
Cytarabine
Dexamethasone
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Mercaptopurine
Methotrexate
Pirarubicin
Prednisolone
Vincristine